MRI-guided hypofractionated intensity-modulated radiation therapy after whole-breast simultaneous integrated boost radiation in early breast cancer: a non-surgical approach

Radical radiotherapy is a novel non-surgical approach to the treatment of early breast cancer. In order to administer a sufficient dose of radiation to the tumor while minimizing the side effects, the exposure to the surrounding normal tissues must be minimized. A 46-year-old woman with early-stage triple-negative breast cancer was treated curatively with MRI-guided hypofractionated intensity-modulated radiation therapy after a whole-breast integrated boost radiation, because the patient refused surgery and chemotherapy. Six months after treatment, the tumor disappeared completely without adjuvant chemotherapy, and there were no recurrences or adverse events two years after treatment. In conclusion, MRI-guided hypofractionated intensity-modulated radiation therapy following simultaneous whole-breast integrated boost radiotherapy may be a feasible alternative treatment for early breast cancer.

Authors

Institutions

Publication Details

Journal
Libri Oncologici Croatian Journal of Oncology
Published
2025-03-06
DOI
https://doi.org/10.20471/lo.2024.52.02-03.20
Primary Topic
MRI in cancer diagnosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MRI-guided hypofractionated intensity-modulated radiation therapy after whole-breast simultaneous integrated boost radiation in early breast cancer: a non-surgical approach

Yukihiro Hama, Etsuko Tate
1 links
Libri Oncologici Croatian Journal of Oncology
MRI in cancer diagnosis
article

MRI-guided hypofractionated intensity-modulated radiation therapy after whole-breast simultaneous integrated boost radiation in early breast cancer: a non-surgical approach

Yukihiro Hama, Etsuko Tate
article en

Abstract

Radical radiotherapy is a novel non-surgical approach to the treatment of early breast cancer. In order to administer a sufficient dose of radiation to the tumor while minimizing the side effects, the exposure to the surrounding normal tissues must be minimized. A 46-year-old woman with early-stage triple-negative breast cancer was treated curatively with MRI-guided hypofractionated intensity-modulated radiation therapy after a whole-breast integrated boost radiation, because the patient refused surgery and chemotherapy. Six months after treatment, the tumor disappeared completely without adjuvant chemotherapy, and there were no recurrences or adverse events two years after treatment. In conclusion, MRI-guided hypofractionated intensity-modulated radiation therapy following simultaneous whole-breast integrated boost radiotherapy may be a feasible alternative treatment for early breast cancer.

Libri Oncologici Croatian Journal of OncologyVol. 52(2-3)
Edogawa Hospital (JP)
Openalex Percentile: Top 94%
MRI in cancer diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MRI-guided hypofractionated intensity-modulated radiation therapy after whole-breast simultaneous integrated boost radiation in early breast cancer: a non-surgical approach — Yukihiro Hama, Etsuko Tate · Libri Oncologici Croatian Journal of Oncology (2025) | TGRS Research Map | TGRS